Rivaroxaban Use for Thrombosis Prophylaxis Is Associated With Early Periprosthetic Joint Infection.

@article{Brimmo2016RivaroxabanUF,
  title={Rivaroxaban Use for Thrombosis Prophylaxis Is Associated With Early Periprosthetic Joint Infection.},
  author={Olubusola A Brimmo and Margaret Glenn and Alison K. Klika and Trevor G Murray and Robert M. Molloy and Carlos Andres Escalante Higuera},
  journal={The Journal of arthroplasty},
  year={2016},
  volume={31 6},
  pages={
          1295-1298
        }
}
BACKGROUND Periprosthetic joint infection is a disastrous complication after total hip arthroplasty (THA) and total knee arthroplasty (TKA). The use of certain agents to prevent deep vein thrombosis after arthroplasty has been linked to an increased risk of adverse effects including wound drainage and infection. Adverse effects of one alternative, rivaroxaban, was studied in a single community hospital. METHODS International Classification of Diseases, Clinical Modification 9 codes were used… CONTINUE READING
9 Citations
26 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Similar Papers

Loading similar papers…